Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
J Afonso, LL Santos, A Longatto-Filho… - Nature Reviews …, 2020 - nature.com
Bladder cancer—the tenth most frequent cancer worldwide—has a heterogeneous natural
history and clinical behaviour. The predominant histological subtype, urothelial bladder …
history and clinical behaviour. The predominant histological subtype, urothelial bladder …
Oxidative stress in prostate hyperplasia and carcinogenesis
UK Udensi, PB Tchounwou - Journal of Experimental & Clinical Cancer …, 2016 - Springer
Prostatic hyperplasia (PH) is a common urologic disease that affects mostly elderly men. PH
can be classified as benign prostatic hyperplasia (BPH), or prostate cancer (PCa) based on …
can be classified as benign prostatic hyperplasia (BPH), or prostate cancer (PCa) based on …
[HTML][HTML] Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms
MK Herroon, E Rajagurubandara, AL Hardaway… - Oncotarget, 2013 - ncbi.nlm.nih.gov
Incidence of skeletal metastases and death from prostate cancer greatly increases with age
and obesity, conditions which increase marrow adiposity. Bone marrow adipocytes are …
and obesity, conditions which increase marrow adiposity. Bone marrow adipocytes are …
PPAR gamma: from definition to molecular targets and therapy of lung diseases
MV Carvalho, CF Gonçalves-de-Albuquerque… - International Journal of …, 2021 - mdpi.com
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor
superfamily that regulate the expression of genes related to lipid and glucose metabolism …
superfamily that regulate the expression of genes related to lipid and glucose metabolism …
The role of PPARγ in prostate cancer development and progression
A Hartley, I Ahmad - British Journal of Cancer, 2023 - nature.com
Advanced and metastatic prostate cancer is often incurable, but its dependency on certain
molecular alterations may provide the basis for targeted therapies. A growing body of …
molecular alterations may provide the basis for targeted therapies. A growing body of …
Transcriptional networks controlling stromal cell differentiation
Stromal progenitors are found in many different tissues, where they play an important role in
the maintenance of tissue homeostasis owing to their ability to differentiate into parenchymal …
the maintenance of tissue homeostasis owing to their ability to differentiate into parenchymal …
Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment
The tumor microenvironment is a complex and dynamic cellular community comprising the
tumor epithelium and various tumor-supporting cells such as immune cells, fibroblasts …
tumor epithelium and various tumor-supporting cells such as immune cells, fibroblasts …
Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levels
The nuclear receptor peroxisome-proliferation-activated receptor gamma (PPARγ), a
transcriptional master regulator of glucose and lipid metabolism, inhibits the growth of …
transcriptional master regulator of glucose and lipid metabolism, inhibits the growth of …
Targeting mitochondrial OXPHOS and their regulatory signals in prostate cancers
CL Chen, CY Lin, HJ Kung - International journal of molecular sciences, 2021 - mdpi.com
Increasing evidence suggests that tumor development requires not only oncogene/tumor
suppressor mutations to drive the growth, survival, and metastasis but also metabolic …
suppressor mutations to drive the growth, survival, and metastasis but also metabolic …
[HTML][HTML] Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
D Austin, N Hamilton, Y Elshimali, R Pietras, Y Wu… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Triple Negative breast cancer (TNBC) is a subtype of breast cancer that lacks the expression
of estrogen receptor (ER), progesterone receptor, and human epidermal growth factor …
of estrogen receptor (ER), progesterone receptor, and human epidermal growth factor …